We are live on
!
Find out more
Pacer Advisors Portfolio holdings
AUM
$35.6B
1-Year Est. Return
18.19%
This Fund
S&P 500
This Quarter
Est. Return
+4.21%
1 Year Est. Return
+18.19%
3 Year Est. Return
+46.13%
5 Year Est. Return
+70.99%
10 Year Est. Return
+394.12%
AUM
$2.21B
AUM Growth
+$402M
(+22%)
Cap. Flow
+$267M
Cap. Flow
% of AUM
12.07%
Top 10 Holdings %
Top 10 Hldgs %
16.09%
Holding
1,247
New
172
Increased
894
Reduced
64
Closed
79
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$8.97M |
| 2 |
Apple
AAPL
|
+$8.92M |
| 3 |
Amazon
AMZN
|
+$8.89M |
| 4 |
Broadcom
AVGO
|
+$8.06M |
| 5 |
BF
BASF AKTIENGESELLT ADS(RP1 ORD
BF
|
+$7.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ABMD
Abiomed Inc
ABMD
|
+$3.45M |
| 2 |
RDS.B
Royal Dutch Shell PLC ADS Class B
RDS.B
|
+$3.39M |
| 3 |
MSCI
MSCI
|
+$3.27M |
| 4 |
Broadridge
BR
|
+$3.02M |
| 5 |
MON
Monsanto Co
MON
|
+$2.94M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.67% |
| 2 | Financials | 12.6% |
| 3 | Healthcare | 11.99% |
| 4 | Consumer Discretionary | 10.38% |
| 5 | Industrials | 9.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
ManpowerGroup
MAN
$2.39B
| $1.76M | 0.08% |
20,505
+2,195
| +12% | +$216K |
|
302
Core Laboratories
CLB
$538M
| $1.76M | 0.08% |
+13,951
| New | +$1.7M |
|
303
Bio-Techne
TECH
$11.2B
| $1.76M | 0.08% |
47,536
+6,848
| +17% | +$261K |
|
|
APC
304
DELISTED
Anadarko Petroleum
APC
| $1.76M | 0.08% |
24,006
+2,879
| +14% | +$195K |
|
|
AXA
305
DELISTED
AXA ADS (1 ORD SHS)
AXA
| $1.75M | 0.08% |
+71,957
| New | +$1.75M |
|
306
Brunswick
BC
$5.19B
| $1.75M | 0.08% |
27,129
+2,898
| +12% | +$181K |
|
307
ENI
E
$76B
| $1.74M | 0.08% |
+46,938
| New | +$1.76M |
|
308
Murphy Oil
MUR
$5.58B
| $1.74M | 0.08% |
51,452
+7,657
| +17% | +$236K |
|
309
Constellation Brands
STZ
$22.2B
| $1.74M | 0.08% |
7,938
+1,364
| +21% | +$308K |
|
310
MDU Resources
MDU
$4.44B
| $1.74M | 0.08% |
159,208
+17,063
| +12% | +$182K |
|
|
CTLT
311
DELISTED
CATALENT, INC.
CTLT
| $1.73M | 0.08% |
41,319
+4,422
| +12% | +$179K |
|
312
Five Below
FIVE
$11.2B
| $1.72M | 0.08% |
+17,596
| New | +$1.41M |
|
|
JHG
313
DELISTED
Janus Henderson
JHG
| $1.72M | 0.08% |
+55,901
| New | +$1.79M |
|
314
Ecolab
ECL
$75.6B
| $1.71M | 0.08% |
12,207
-2,591
| -18% | -$374K |
|
315
United Therapeutics
UTHR
$26.3B
| $1.71M | 0.08% |
15,129
+2,454
| +19% | +$270K |
|
316
PACCAR
PCAR
$69.6B
| $1.71M | 0.08% |
41,378
+7,268
| +21% | +$314K |
|
317
Aptiv
APTV
$12B
| $1.71M | 0.08% |
+18,628
| New | +$1.74M |
|
|
SIX
318
DELISTED
Six Flags Entertainment Corp.
SIX
| $1.71M | 0.08% |
24,363
+2,602
| +12% | +$170K |
|
|
LOGM
319
DELISTED
LogMein, Inc.
LOGM
| $1.71M | 0.08% |
16,512
+29
| +0.2% | +$3.24K |
|
320
Charles River Laboratories
CRL
$10.9B
| $1.7M | 0.08% |
15,159
+2,034
| +15% | +$220K |
|
321
Baxter International
BAX
$11.6B
| $1.7M | 0.08% |
23,017
+3,844
| +20% | +$271K |
|
322
Bank OZK
OZK
$5.49B
| $1.7M | 0.08% |
37,637
+4,032
| +12% | +$192K |
|
323
Microchip Technology
MCHP
$42.8B
| $1.69M | 0.08% |
37,090
+5,634
| +18% | +$261K |
|
324
Lincoln Electric
LECO
$13.8B
| $1.68M | 0.08% |
19,124
+2,047
| +12% | +$182K |
|
|
FLG
325
Flagstar Bank National Association
FLG
$5.77B
| $1.68M | 0.08% |
50,645
+5,424
| +12% | +$195K |
|
Similar funds
SAM
Pacer Advisors's Q2 2018 Portfolio in Review
As of Q2 2018, Pacer Advisors held 1,247 positions worth $2.21B, up 22% from $1.81B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Pacer Advisors deployed $267M of net new capital in Q2 2018, opening 172 new positions and adding to 894 existing holdings. Its largest new stake was Broadcom: 328,700 shares worth $7.98M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Abiomed Inc, an estimated $3.45M trimmed.
- Pacer Advisors's largest Q2 2018 buy was Broadcom: 328,700 shares worth $7.98M.
- Pacer Advisors added most to Microsoft in Q2 2018, an estimated $8.97M increase.
- Pacer Advisors's biggest Q2 2018 reduction was Abiomed Inc, cutting an estimated $3.45M.
- Pacer Advisors fully exited Royal Dutch Shell PLC ADS Class B in Q2 2018, selling an estimated $3.39M.
- Pacer Advisors's ten largest holdings make up 16% of its $2.21B portfolio in Q2 2018.
- Pacer Advisors opened 172 new positions and closed 79 in Q2 2018.
- Pacer Advisors's portfolio value rose 22% quarter-over-quarter to $2.21B.
Based on Pacer Advisors's 13F filing for Q2 2018, filed 14 Aug 2018.